Shandong Luoxin Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Luoxin Pharmaceutical") is a large pharmaceutical enterprise group integrating drug research and development, production, trade, and medical health services. Since 2006, Luoxin Pharmaceutical has been consecutively ranked among the Top 100 Enterprises in China's Pharmaceutical Industry, and since 2011, it has been rated as a Top Industrial Enterprise in China's Pharmaceutical R&D Product Line. It is a National Key High-Tech Enterprise, a National Technology Innovation Demonstration Enterprise, and a National Industrial Quality Benchmark Enterprise. Luoxin Pharmaceutical focuses on independent innovation, with over 200 product technologies granted national invention patents. It has won multiple national and provincial awards, including the Second Prize of the National Science and Technology Progress Award and the First Prize of Provincial Science and Technology Progress Awards. Several products have been included in major national scientific and technological projects such as the "National Key New Product Plan," the "National Torch Plan," and the "Major New Drug Creation" program. The company has production and R&D bases in Shandong, Shanghai, and other places in China, with nearly 7,000 employees.
Luoxin Pharmaceutical (Shanghai) Co., Ltd. is a drug R&D company invested and established by Shandong Luoxin Pharmaceutical Group Co., Ltd. In 2016, the company was recognized as a High-Tech Enterprise, and in 2018, it was recognized as a Shanghai Patent Work Pilot Unit and a Pudong New Area Enterprise R&D Institution, and it has a joint laboratory with the Center for Biological and Chemical Cross-Disciplinary Research of the Chinese Academy of Sciences.
Since its establishment, the company has adhered to the product R&D strategy of "looking forward to the long term, balancing current needs, and synchronizing innovation and generics." Relying on the support of the Luoxin Group and the advantages of Zhangjiang High-Tech Park, it is committed to building a fully integrated Luoxin R&D base, which will gradually develop into the R&D headquarters of the Luoxin Pharmaceutical Group. The company is mainly dedicated to the development of molecular targeted anti-tumor innovative drugs and generics with high clinical value, involving major disease treatment areas such as the digestive system, respiratory system, cardiovascular system, antibiotics, and anti-tumor.
What does Luoxin Pharmaceutical (Shanghai) Co., Ltd. require? Who is Luoxin Pharmaceutical (Shanghai) Co., Ltd. hiring? recruitment: 经营管理类占比最多占47.4%，其次是人力资源类占15%. What education can get in at ? 本科占比最多占78.2%，其次是大专占11.3%. High education required at ? 硕士占9.8%，博士占0.8%. Work experience required at ? 5-10年占比最多占43.6%，其次是不限占23.3%. Where are the job locations at ? 上海占比最多占50.4%，其次是临沂占27.8%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
